<p>The transaction terms indicate that WuXi XDC's holder, Huanquan Pharmaceutical Hong Kong Investment Co., Ltd., seeks to raise up to HKD 2.4 billion through a block trade: issuing 30.3 million shares, priced at HKD 77 to HKD 79.07 per share, representing a discount of 4.5% to 7% compared to Wednesday's closing price of HKD 82.80, accounting for approximately 2.47% of the existing shares outstanding, with a 90-day lock-up period for the seller, and Morgan Stanley serving as the exclusive bookrunner</p>

02268

<p>The transaction terms indicate that WuXi XDC's holder, Huanquan Pharmaceutical Hong Kong Investment Co., Ltd., seeks to raise up to HKD 2.4 billion through block trades: issuing 30.3 million shares, priced at HKD 77 to HKD 79.07 per share, representing a discount of 4.5% to 7% compared to Wednesday's closing price of HKD 82.80, accounting for approximately 2.47% of the existing circulating shares, with a 90-day lock-up period for the seller, and Morgan Stanley serving as the exclusive bookrunner</p>

Document: WuXi XDC holders seek to raise up to HKD 2.4 billion through block trades